Scientists from the University of Würzburg have discovered a promising approach to treat a genetically caused nervous disease. Instead of resorting to gene therapy, the scientists have targeted phagocytes they identified as promoters of the disease.
Charcot-Marie-Tooth (CMT) disease is a group of inherited disorders of the peripheral nervous system characterised by loss of nerve fibres, muscle tissue and impaired touch sensation. Early symptoms include paralysis and loss of muscle tissue in the feet and legs expanding to the hands and lower arms as the disease progresses. In severe cases, sufferers need a wheelchair; and there is no efficient therapy available at present.
Publication in the journal Brain
This could change in the foreseeable future: Scientists at the Department of Neurology of the University Hospital of Würzburg have found a target for therapy that was successfully applied in animal tests. The team of Professor Rudolf Martini, head of Experimental Developmental Neurobiology at the Department of Neurology has now published these findings in the renowned journal Brain.
"Normally, one would expect a gene therapy approach when treating an inherited disease," Martini explains. But he and his team took a different direction: They blocked a receptor on the surface of special cells of the immune system, the so-called macrophages.
A semiochemical gives the cue to attack
In previous studies conducted over several years, the scientists had used model mice to demonstrate that these macrophages cause the genetically predisposed nerve damage to occur in the first place. "You could say that they act as a promoter of the disease," Martini further. A special semiochemical, the cytokine colony-stimulating factor (CSF) -1, signals the macrophages to attack the nerve fibres.
"Astonishingly, CSF-1 is not expressed by the mutated Schwann cells, but by hitherto neglected nerve fibroblasts," Martini says. Schwann cells form the myelin sheaths in the peripheral nervous system which act as a kind of insulation of the myelinated nerve fibres. Moreover, they are essential for the survival of the nerve fibres and thus for keeping the nerves functional.
Even though around 80 disease genes have been identified for CMT neuropathies so far, the three most common forms of this disorder are caused by mutations of myelin associated genes of the Schwann cells. How the fibroblasts are informed about the defective Schwann cells is still unknown, but the scientists hope to decipher the mechanism during further studies.
Visible successes without side effects
In the study, the scientists fed a synthetic CSF-1 receptor inhibitor to mice suffering from CMT. As a result, the symptoms of two different forms of CMT were alleviated significantly and without side effects. The muscular strength experiments were particularly impressive and relevant for patients: "While untreated model mice lost up to 25 percent of their muscular strength due to the disease, the treated mutants cannot be distinguished from their healthy counterparts in terms of muscular strength," Martini says.
Hopes for a quick transfer to clinical practice
The scientists now believe that this approach is also highly significant for the treatment of humans. "Similar inhibitors are already being used in clinical studies to treat rheumatoid arthritis and different tumours," Martini explains. Protracted approval procedures to use the inhibitor on humans are thus already under way.
Dr. Brian West is one of the co-authors of the study besides the members of Martini's team. He is the research director of the Californian company Plexxikon which developed the inhibitor. The study has already drawn much attention, for example, in the form of a scientific comment by Professor Steven S. Scherer (Philadelphia), an international expert in CMT. In addition to Deutsche Forschungsgemeinschaft, the project received considerable funding from Charcot-Marie-Tooth Association in the US, which recently appointed Professor Rudolf Martini to its scientific advisory board.
According to Martini, the successful research project demonstrates that after exploring all other possibilities animal experiments are crucial to finding new approaches to treat and ultimately heal so far incurable human diseases.
Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot–Marie–Tooth disease in mice. Dennis Klein, Ágnes Patzkó , David Schreiber, Anemoon van Hauwermeiren, Michaela Baier, Janos Groh, Brian L. West and Rudolf Martini. BRAIN, published online August 21, 2015. doi:10.1093/brain/awv240
Prof. Dr. Rudolf Martini, Phone: +49 931 201-23268, firstname.lastname@example.org
Gunnar Bartsch | idw - Informationsdienst Wissenschaft
Improving memory with magnets
28.03.2017 | McGill University
Graphene-based neural probes probe brain activity in high resolution
28.03.2017 | Graphene Flagship
The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.
To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
28.03.2017 | Life Sciences
28.03.2017 | Information Technology
28.03.2017 | Physics and Astronomy